| UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins CW Lo, R Matsuura, K Iimura, S Wada, A Shinjo, Y Benno, M Nakagawa, ... Scientific reports 11 (1), 13804, 2021 | 77 | 2021 |
| BoLA-DRB3 polymorphism is associated with differential susceptibility to bovine leukemia virus-induced lymphoma and proviral load CW Lo, L Borjigin, S Saito, K Fukunaga, E Saitou, K Okazaki, T Mizutani, ... Viruses 12 (3), 352, 2020 | 70 | 2020 |
| SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein R Matsuura, CW Lo, S Wada, J Somei, H Ochiai, T Murakami, N Saito, ... Viruses 13 (5), 942, 2021 | 64 | 2021 |
| Association of bovine leukemia virus-induced lymphoma with BoLA-DRB3 polymorphisms at DNA, amino acid, and binding pocket property levels CW Lo, S Takeshima, K Okada, E Saitou, T Fujita, Y Matsumoto, S Wada, ... Pathogens 10 (4), 437, 2021 | 27 | 2021 |
| Phosphoproteomics identified an NS5A phosphorylation site involved in hepatitis C virus replication WM Chong, SC Hsu, WT Kao, CW Lo, KY Lee, JS Shao, YH Chen, ... Journal of Biological Chemistry 291 (8), 3918-3931, 2016 | 24 | 2016 |
| Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies M Karim, S Saul, L Ghita, MK Sahoo, C Ye, N Bhalla, CW Lo, J Jin, ... Antiviral Research 204, 105367, 2022 | 18 | 2022 |
| Risk Assessment of Bovine Major Histocompatibility Complex Class II DRB3 Alleles for Perinatal Transmission of Bovine Leukemia Virus L Borjigin, CW Lo, L Bai, R Hamada, H Sato, S Yoneyama, A Yasui, ... Pathogens 10 (5), 502, 2021 | 17 | 2021 |
| Serine 235 is the primary NS5A hyperphosphorylation site responsible for hepatitis C virus replication SC Hsu, CW Lo, TC Pan, KY Lee, MJ Yu Journal of Virology 91 (14), 10.1128/jvi. 00194-17, 2017 | 16 | 2017 |
| Bovine major histocompatibility complex (BoLA) heterozygote advantage against the outcome of bovine leukemia virus infection CW Lo, S Takeshima, S Wada, Y Matsumoto, Y Aida HLA 98 (2), 132-139, 2021 | 14 | 2021 |
| Sequential S232/S235/S238 phosphorylation of the hepatitis C virus nonstructural protein 5A SC Hsu, CN Tsai, KY Lee, TC Pan, CW Lo, MJ Yu Journal of Virology 92 (20), 10.1128/jvi. 01295-18, 2018 | 13 | 2018 |
| Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle CW Lin, CW Lo, CN Tsai, TC Pan, PY Chen, MJ Yu International Journal of Molecular Sciences 19 (1), 208, 2018 | 12 | 2018 |
| Vigna radiata (L.) R. Wilczek Extract Inhibits Influenza A Virus by Targeting Viral Attachment, Penetration, Assembly, and Release CW Lo, CC Pi, YT Chen, HW Chen Frontiers in Pharmacology 11, 584973, 2020 | 11 | 2020 |
| Preparing for the next viral threat with broad-spectrum antivirals M Karim, CW Lo, S Einav Journal of Clinical Investigation 133 (11), e170236, 2023 | 8 | 2023 |
| Distinct MCM10 proteasomal degradation profiles by primate lentiviruses Vpr proteins H Chang, L Siarot, R Matsuura, CW Lo, H Sato, H Otsuki, Y Aida Viruses 12 (1), 98, 2020 | 7 | 2020 |
| Differential proteomics reveals discrete functions of proteins interacting with hypo-versus hyper-phosphorylated NS5A of the hepatitis C virus TC Pan, CW Lo, WM Chong, CN Tsai, KY Lee, PY Chen, JC Liao, MJ Yu Journal of proteome research 18 (7), 2813-2825, 2019 | 6 | 2019 |
| Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects S Saul, M Karim, L Ghita, PT Huang, W Chiu, V Durán, CW Lo, S Kumar, ... The Journal of Clinical Investigation 133 (19), 2023 | 5 | 2023 |
| Comparison of the inactivation capacity of various UV wavelengths on SARS-CoV-2 R Matsuura, CW Lo, T Ogawa, M Nakagawa, M Takei, Y Matsumoto, ... Biochemistry and Biophysics Reports 32, 101379, 2022 | 5 | 2022 |
| Association between BoLA‐DRB3 polymorphism and bovine leukemia virus proviral load in Vietnamese Holstein Friesian cattle TD Le, VS Nguyen, CW Lo, DT Dao, NV Bui, H Ogawa, K Imai, K Sugiura, ... Hla 99 (2), 105-112, 2022 | 4 | 2022 |
| Association of BoLA-DRB3 with bovine leukemia virus CW Lo, Y Aida Major Histocompatibility Complex 29 (3), 158-167, 2022 | 2 | 2022 |
| Chemical inactivation strategies for SARS-CoV-2-infected cells and organoids M Karim, AA Pohane, CW Lo, S Einav, J Garhyan STAR protocols 5 (1), 102906, 2024 | 1 | 2024 |
